Kukjeon Pharmaceutical Co Ltd Ordinary Shares 307750
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 5,640.00–5,740.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 5,640.00 / KRW 5,640.00
- Market Cap
- KRW 276.75 Bil
- Volume/Avg
- 52,119 / 894,709
Key Statistics
- Price/Earnings (Normalized)
- 95.45
- Price/Sales
- 2.27
- Dividend Yield (Trailing)
- 0.18%
- Dividend Yield (Forward)
- 0.18%
- Total Yield
- 0.18%
Company Profile
Kukjeon Pharmaceutical Co Ltd supplies raw materials to domestic and foreign pharmaceutical companies and electronic material companies. Some of the products of the company include Artemisia Princeps Folium 95% ethanol soft extract, Bilberry Fruit Dry Extract, Dexibuprofen, Megestrol Acetate, and Benfotiamine.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Growth
- Total Number of Employees
- 163
- Website
- http://www.kukjeon.co.kr
Comparables
Valuation
|
Metric
|
307750
|
000640
|
140410
|
|---|---|---|---|
Price/Earnings (Normalized) | 95.45 | 19.98 | — |
Price/Book Value | 2.87 | 0.68 | 21.62 |
Price/Sales | 2.27 | 0.60 | 33.52 |
Price/Cash Flow | 27.51 | 4.99 | — |
Price/Earnings
307750
000640
140410
Financial Strength
|
Metric
|
307750
|
000640
|
140410
|
|---|---|---|---|
Quick Ratio | 0.94 | 0.44 | 2.17 |
Current Ratio | 1.24 | 0.66 | 2.51 |
Interest Coverage | 1.03 | 3.70 | −43.24 |
Quick Ratio
307750
000640
140410
Profitability
|
Metric
|
307750
|
000640
|
140410
|
|---|---|---|---|
Return on Assets (Normalized) | 2.33% | 3.28% | −17.65% |
Return on Equity (Normalized) | 5.21% | 6.15% | −33.91% |
Return on Invested Capital (Normalized) | 4.97% | 4.65% | −28.13% |
Return on Assets
307750
000640
140410
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Ynfgvhqns | Bcqg | $698.5 Bil | |
JNJ
| Johnson & Johnson | Gxcmkfctm | Lrw | $359.2 Bil | |
MRK
| Merck & Co Inc | Ygnplygt | Bgc | $323.0 Bil | |
ABBV
| AbbVie Inc | Dtvjpmrh | Jgrp | $289.2 Bil | |
AZN
| AstraZeneca PLC ADR | Krlxmznv | Pdskk | $236.3 Bil | |
NVS
| Novartis AG ADR | Zpllhwpm | Ywm | $197.3 Bil | |
RHHBY
| Roche Holding AG ADR | Yjlljytxj | Zjh | $192.5 Bil | |
AMGN
| Amgen Inc | Clhvmxwxcv | Dpx | $167.0 Bil | |
PFE
| Pfizer Inc | Bmtqfptr | Yjnb | $157.5 Bil | |
SNY
| Sanofi SA ADR | Nzzdpbfv | Rrlpz | $122.3 Bil |